Pacific Biosciences of California Inc. buy Stephens
Start price
14.12.23
/
50%
€8.42
Target price
14.12.24
€10.05
Performance (%)
-76.65%
Price
22:26
€1.97
Summary
This prediction is currently active. Massive losses of -76.65% have been the result for the BUY prediction by Stephens. This prediction currently runs until 14.12.24. The prediction end date can be changed by Stephens at any time. Stephens has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Pacific Biosciences of California Inc. | 10.325% | 10.325% |
iShares Core DAX® | 0.039% | 0.567% |
iShares Nasdaq 100 | -4.018% | -5.554% |
iShares Nikkei 225® | -2.389% | -1.434% |
iShares S&P 500 | -2.115% | -2.351% |
Comments by Stephens for this prediction
In the thread Pacific Biosciences of California Inc. diskutieren
Pacific Biosciences of California, Inc. (NASDAQ: PACB) is now covered by analysts at Stephens. They set an "overweight" rating and a $11.00 price target on the stock.
Ratings data for PACB provided by MarketBeat